Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions.
Lameris, R., Shahine, A., Veth, M., Westerman, B., Godfrey, D.I., Lutje Hulsik, D., Brouwer, P., Rossjohn, J., de Gruijl, T.D., van der Vliet, H.J.(2023) J Immunother Cancer 11
- PubMed: 38040419 
- DOI: https://doi.org/10.1136/jitc-2023-007631
- Primary Citation of Related Structures:  
8SOS - PubMed Abstract: 
CD1d is a monomorphic major histocompatibility complex class I-like molecule that presents lipid antigens to distinct T-cell subsets and can be expressed by various malignancies. Antibody-mediated targeting of CD1d on multiple myeloma cells was reported to induce apoptosis and could therefore constitute a novel therapeutic approach.
Organizational Affiliation: 
Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.